| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Science Entrepreneur Club Building communities. Enabling innovation. Connecting the life science ecosystem. We’re a non-profit on a mission to build meaningful communities to enable innovation and connect the life science ecosystem. We're building communities for entrepreneurs building in bio, investors actively backing life science companies and academics looking to break into industry. The SEC is the home of the BioFounder Club, BioCapital Network and BioAcademic Hub. entrepreneurship, innovation, science, engineering, life science, biotech, startup, networking, technology, and health Type: | 10 | 0 | 11 | 25 |
 | Calm/Storm Entrepreneurship is a continuous storm Calm/Storm is an exclusive founder network and boutique venture capital firm. We focus on talents, not industries. We believe in lifelong learning & personal growth, empowering entrepreneurs with unique access to successful founders. We are a fund built by founders for founders. Type: | 15 | 4 | 14 | 34 |
 | Jolt Capital Scaling responsible deeptech companies Jolt Capital SAS is a fully independent Private Equity firm authorized and regulated by AMF (Autorité des Marchés Financiers) that specialises in Technology, targeting investments into companies with revenues between €10m and €50m. Jolt Capital generates returns for its investors by enabling mid-sized technology-rich companies with strong fundamentals to execute their growth strategies, in sectors that offer good exit potential across software and hardware alike (cybersecurity, sensors, photonics, industrial processes, new energy systems, applied AI, robotics...) In providing growth capital to our portfolio companies, we support their scaling in new markets, new capacities and new acquisitions, … Type: | 89 | 8 | 86 | 33 |
 |  Phytolon Natural Food Colors Phytolon offers natural food colors, uniquely positioned to comply with the consumers needs for healthy food, and with the industry requirements for cost-efficiency and high quality. Phytolon leverages a novel and sustainable fermentation-based technology by which betalain natural colors are produced in baker's yeast. food colors, natural ingredients, yeast, fermentation, sustainability, biotechnology, and foodtech Type: | 2 | 0 | 2 | 27 |
 | Regeneration.VC Supercharging Consumer-Powered Climate Innovation Regeneration.VC is an early-stage venture fund Supercharging Consumer-Powered Climate Innovation driven by circular and regenerative principles. We invest in Consumer ClimateTech companies that generate outsized economic and environmental outcomes across three strategies: Design (AgTech & Aquaculture and Next-Gen Materials), Use (Apparel & Lifestyle and Food & Beverage brands), and Reuse (ReCommerce and Reverse Logistics system technologies). Have an innovation ready to supercharge? Submit here: https://form.fillout.com/t/dDYPidgNx4us Circular Economy, Sustainable Investing, Venture Capital, Consumer, Climate Tech, Regeneration, and Consumer ClimateTech Type: | 36 | 0 | 36 | 21 |
 | Marsh We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We seek better ways to manage risk and define more effective paths to the right outcome. We go beyond risk to rewards for our clients, our company, our colleagues, and the communities in which we serve. Marsh is the world’s leading insurance broker and risk advisor. With over 45,000 colleagues operating in 130 countries, Marsh serves commercial and individual clients with data-driven risk solutions … Type: | 10 | 7 | 3 | 12 |
 | Mosaic TX An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients. ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety … Type: | 2 | 1 | 1 | 31 |
 | Virtonomy.io Accelerate and de-risk medical device development with digital patient twins and simulation Virtonomy introduces v-Patients, enabling medical device developers to perform development and testing in a virtual environment, thereby accelerating development, reducing risks, expenses, and regulatory burden. Our end-to-end digital twin and simulation solution is based on an ever-expanding database of real clinical data to reflect anatomical variability, demographic diversity and pathological conditions. digital health, virtual patients, digital twins, clinical trials, simulation, machine learning, AI, SaaS, simulated trials, cardiac database, and medtech Type: | 4 | 0 | 4 | 26 |
 |  deepc Increasing diagnostic quality through the collaboration of medical professionals and AI. deepc is a pioneering company in the realm of Radiology AI, poised to democratize access to health at scale. At the heart of our mission is ourproduct deepcOS®, an unrivaled cloud-native Radiology AI platform. With a vendor-agnostic approach, deepcOS® boasts an expansive repository of cutting-edge AI applications. This groundbreaking platform empowers radiologists to seamlessly include AI insights into their clinical workflows, ushering in a new era of patient care excellence and elevated diagnostic precision. Visit our website now or simply email us at contact@deepc.ai Digital Health, Deep Learning, Machine … Type: | 1 | 1 | 0 | 74 |
 | 2CFinance [Automatic translation follows] Independent financial consulting firm, specializing in Transaction Services and DAF Part Time Our mission: “Advise investors and managers to diagnose and improve the quality and performance of corporate financial departments”. • Consulting company, based in Paris 9th, Aix-en-Provence and Nantes. • Two professions: delegated operational financial management and financial consulting. • A team of 50 employees. • More than 500 missions carried out in Small and MidCap companies, while respecting absolute discretion and confidentiality. • A portfolio of renowned entrepreneurs, executives and investment funds. • Long experience of supporting companies in different key phases of their development … | 44 | 9 | 38 | 96 |
 | mind Health [Automatic translation follows] The business intelligence service dedicated to the digital transformation of healthcare industries. mind Health is a B2B service offering dedicated to the transformation of health industries, innovation and the transformation of the value chain in the health ecosystem. Offering information, monitoring and analysis, mind Health is aimed at all the players and sectors that make up this ecosystem: pharmaceutical and medical device industries, electronics, IT and telecoms, mutual funds and insurance, healthcare services. public and private, service providers... Type: | 70 | 3 | 69 | 4 |
 | Pixium Vision S.A. Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission … Type: | 7 | 5 | 1 | 47 |
 | Cardiologs AI Serving Cardiology Cardiologs is a medical technology company on a mission to democratize expert cardiac care through medical-grade artificial intelligence. Machine Learning, Big Data, MedTech, Cardiology, Artificial Intelligence, ECG analysis, Holter analysis, and SaaS Type: | 14 | 9 | 3 | 88 |
 | MedTech in France [Automatic translation follows] We are the French medical technology companies, we innovate every day for patients! Created in 2013, MedTech in France currently brings together more than 40 French companies in the health MedTech sector. and telemedicine, optical technologies, surgical robotics, and even medical imaging. The Association develops concrete solutions to promote market access, innovations and highlight French excellence in medical technologies. It has also set itself the mission of creating French champions internationally. MedTech in France has set itself a triple ambition: > provide medical solutions for patients and caregivers > bring economic and organizational benefits to the health … Type: | 25 | 4 | 22 | 7 |
 | Endpoints News The biopharma world is here Endpoints is the biopharma world's leading source for breaking news, smart analysis and exclusive access. We cover the intersection of science, money and power in the world's most innovative industry, and are a part of the Financial Times' FT Specialist group. Biotechnology, News, Drug Development, and Pharmaceuticals Type: | 20 | 3 | 19 | 62 |
 | Founders Future Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and digital startups. Founded by the serial European tech entrepreneur, Marc Ménasé, Founders Future is a venture studio, providing creativity, network, support and productive capital. We've built a investment platform dedicated to entrepreneurs and managed by entrepreneurs, bringing high value and an ambitious mindset. We aim to partner with outstanding personalities, to align stakeholder’s interest and to foster operational partnerships. Our mission is to become a sparring-partner and continuously try to impact the business on the product, go-to-market, business development and talent acquisition. We've hired top-notch operating … Type: | 64 | 26 | 50 | 19 |
 | Sitryx Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … Type: | 3 | 2 | 3 | 51 |
 | GTM Forum Navigate the Go to market landscape GTM Forum is your premier analyst partner in go-to-market strategies, serving leading B2B companies worldwide. Our expertise across multiple sectors uniquely positions us to address your complex challenges effectively. With our broad knowledge base and global reach, we are dedicated to making a significant impact on both our clients and the community. We create a collaborative environment that boosts your team's capabilities and leadership, providing tailored support to tackle fundamental issues and offer practical solutions. Our mission is to empower your organization to drive and maintain progress in your strategic endeavors. Specializing in mid-market … Type: | 33 | 0 | 33 | 23 |
 | Enersens Enersens produces the best thermal barriers and additives to improve safety, energy efficiency and flame protection Enersens is a leading innovative company specializing in silica aerogel products. We develop and market high performance aerogel-based insulation materials. We aim to become the leader in these high performance materials to enable our customers and partners to achieve their own goals around global trends in energy efficiency, sustainability, electric mobility and clean energy. Our Skogar® products solve the thermal runaway problems of batteries for any type of electric vehicle or electric mobility. Their performance and finesse also make it possible to solve many … Type: | 23 | 5 | 21 | 7 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 11 | 7 | 5 | 123 |
 | VITAL MEAT Sustainable, healthy and delicious cultivated meat 🌎🍴 VITAL MEAT is a cultivated meat start-up based out of Nantes, France 🇫🇷 Our mission is to reduce human impact on the environment by providing HEALTHY, DELICIOUS, ETHICAL and SUSTAINABLE meat to billions of people 🌎 Thanks to our scalable technology and a cost effective process, we are gearing up to commercialize our first chicken product 🐔! Type: | 12 | 4 | 9 | 13 |
 | Index Ventures Index helps the most ambitious entrepreneurs turn bold ideas into global businesses. Index Ventures partners with exceptional entrepreneurs – those with unique insight who are intrinsically driven to make their vision a reality. We help them turn their bold ideas into global businesses, and through the companies they build, have a long-lasting and positive impact on the world around us. Index-backed businesses are supported by an experienced team of investors, strategists, and an extensive global network built over three decades of startup investing. Working side-by-side through the scale up journey, we forge deep and long-lasting relationships with founders and their … | 11 | 7 | 3 | 114 |
 | PariSanté Campus [Automatic translation follows] ParisSanté Campus, here grows digital health! PariSanté Campus aims to create a coherent and synergistic set of public and private operators, with the ambition of structuring a digital health research and innovation sector with global reach. This group will aim to be established on the site of the former Val-de-Grâce army training hospital, and to create a network of Ile-de-France, national and international partnerships. The whole will be financed by unprecedented investments from the recovery plan, and will be intended to be a major vector for creating medical-scientific, but also economic, value. Based on a complete chain … Type: | 77 | 24 | 47 | 20 |
 | Académie des technologies [Automatic translation follows] For reasoned progress, chosen shared Founded in 2000, the Academy of Technologies brings together 370 academics, including five Nobel Prize winners, all experts in their respective fields, and from very diverse backgrounds: the world of industrial and academic research, economists, sociologists, architects. , doctors, etc. It analyzes the opportunities and risks linked to new technologies, and is committed to improving the attractiveness of technological professions, particularly among young people and women. The Academy issues proposals and recommendations to public authorities, socio-economic stakeholders and citizens for better exploitation of technologies for the benefit of people, in accordance with … Type: | 64 | 12 | 69 | 85 |
 | SISTAFUND We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams. SISTAFUND is a pan-European VC fund backing female founders and gender-balanced teams, building companies that challenge the status quo. With a target of €100 million, SISTAFUND will be deployed from pre-seed to Series A, mainly in France and Europe, with some investments in the U.S. SISTAFUND’s ambition is twofold: Drive the performance of backed companies, since start-ups founded or co-founded by women are 2.5 times more profitable investments … Type: | 48 | 11 | 45 | 7 |
 | Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: | 4 | 1 | 2 | 21 |
 | Womed This is a women's world Womed is pioneering innovative, safe and effective treatments to free women from challenging uterine pathologies: infertility, uterine bleeding, endometriosis. Type: | 10 | 1 | 1 | 12 |
 | Umiami The next generation of plant-based meat. Tasty, Tender, and Sustainable whole-cuts. Umiami is a French foodtech that was founded in 2020 with the mission to reduce worldwide meat consumption and its impact on health, animals, and the environment. We are pioneers in the development of a patent-pending process for texturizing plant proteins called "umisation". With our umisation technology, we can recreate the meat and fish fillet experience without compromising on taste and texture. After opening our first pilot plant innovation center last year, Umiami will inaugurate its first large-scale production plant in October 2023. The 14,000m2 site is located in … Tags: FrenchTech2030 Type: | 34 | 19 | 20 | 105 |
 | Home Biosciences A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model Type: | 5 | 4 | 2 | 9 |
 | BIOTECHFINANCES [Automatic translation follows] 1st weekly specialist information, biotech, medtech, e-health, finance published by Jacques Bernard Taste PRESENTATION The weekly Biotech Finances letter approaches from an economic and financial angle all questions linked to the development of the biotechnology sector and more broadly life sciences. Our target readership is mainly composed of biotechnology companies focused on health and the development of new therapies and new treatments for diseases, pharmaceutical companies (big pharma and other laboratories), investors, business angels, funds investments, venture capital, specialized in the biotech sector, institutional investors, legal advisors, development experts, and service providers and equipment suppliers. Our articles … Type: | 13 | 4 | 3 | 9 |
 | Form the Future CIC We help young people find their route through education into employment, and provide employers access to future talent We connect young people to a world of career possibilities, inspire them to dream big and empower them to fulfil their potential. We want to equip young people with the experience and skills they will need to succeed in their career of choice, and enable businesses to recruit skilled workers locally. We bridge the gap between these two worlds and help them work together and achieve more. We deliver the skills service for the Greater Cambridge Partnership, linking schools and businesses to … Type: | 10 | 0 | 8 | 37 |
 | Tigem Telethon Institute of Genetics and Medicine TIGEM is a multidisciplinary research Institute devoted to the study of the mechanisms underlying rare genetic diseases and to the development of new therapies. The institute is one of the most important centers for fundamental life science research in Italy (https://www.tigem.it/). It is particularly renowned for its research on diseases such as lysosomal disorders, membrane trafficking defects, disorders of liver metabolism, and eye diseases. The unique funding environment of TIGEM forges important critical mass and facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. TIGEM is a … Type: | 1 | 1 | 1 | 299 |
 | Novozymes Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel … Type: | 12 | 2 | 11 | 4,489 |
 | Bien Commun Advisory [Automatic translation follows] The conviction that, in the “common good”, the greatest good is first and foremost what is common to us. Bien Commun Advisory is a consulting firm in communications strategy, economic information, public affairs and media relations. Founded by Antoine Boulay in 2019, it now has around fifteen employees and operates for large companies, SMEs, start-ups, federations and players in the associative world. Type: | 34 | 1 | 29 | 14 |
 | Noema Pharma Developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS | 1 | 1 | 0 | 32 |
 | ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 4 | 0 | 2 | 17 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 11 |
 | EnginZyme Developing technologies to meet the sustainability goals of the future Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the … Type: | 2 | 0 | 2 | 59 |
 | Institut G9+ L'Interclubs Numérique des Alumni des Grandes Écoles & Universités The G9 + Institute is a plural and apolitical think tank, promoting digital development in France. Federating 24 graduate communities of universities and colleges, and 50000 alumni, the G9 + Institute is one of the reference think tanks of digital for more than 22 years. Engaged in its historical mission of consultative source of proposals, the G9 + Institute wants to allow its members and friends to confront their ideas, deepen them and make them known. It brings an investigative, constructive and audacious light by publishing white papers and organizing about … Type: | 43 | 12 | 30 | 11 |
 | Frst We are the first believers Frst is a Day One venture firm focused on supporting a new generation of French entrepreneurs with global ambitions. €200m+ AUMA invested in 50+ companies to date. Full portfolio on frst.vc Type: | 5 | 4 | 0 | 6 |
 | Mauna Kea Technologies The real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients. Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative … Type: | 3 | 1 | 2 | 121 |
 | Le Monde [Automatic translation follows] The leading news, everywhere, all the time, from the editorial staff of Le Monde. LeMonde.fr has been present on the Internet since December 19, 1995, 51 years to the day after the creation of the paper newspaper. The site and its mobile applications are among the most consulted in France to follow news in real time (international, economy, politics, society, etc.) Leading news website in French. Journalism, Media, Online Press, Written Press, Internet, Video, and Ethics Type: | 274 | 196 | 76 | 2,722 |
 | La French Care [Automatic translation follows] The movement of health actors Our mission ? Federate the health ecosystem. French Care is the movement of health actors, it is supported by Bpifrance and the Acteurs de la French Care association, which brings together private and public actors in the health sector in France. French Care serves the development of ecosystems and excellence in the service of the patient. The mission of La French Care: to promote and develop excellence in health in France. Type: | 18 | 10 | 8 | 6 |
 | La Course des Lumières [Automatic translation follows] Together, let's light up the night against illness and for all sick people! Created in 2010, the Race of Lights is a national awareness event around the fight against disease. Since its creation, more than a million euros have been collected for the benefit of health organizations (foundations, hospitals, patient associations, etc.). Accessible to all, the event brings together more than 15,000 participants and 200 companies each year. Each participant, runner or walker, symbolically carries a luminous object to “light the night against illness and for all sick people”. solidarity, sport, running, walking, and team-building Type: | 5 | 5 | 1 | 1 |
 | ELICIT PLANT The only efficient Bio-Intrant to fight Water Stress ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit Plants develops a methodology to collect soil, … Tags: FrenchTech2030 Type: | 18 | 10 | 11 | 76 |
 | Neoplants The first generation of plants bioengineered to fight air pollution. www.neoplants.com The first generation of bioengineered plants to fight air pollution. | 15 | 10 | 8 | 37 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 9 | 8 | 1 | 61 |
 | Merieux Equity Partners Invested Investors Merieux Equity Partners is a multistage investment manager specialized in the healthcare & nutrition sectors via two dedicated platforms: Venture and Growth/Buyout. As an independent General Partner - registered under the French Financial Markets Authority AMF ("Autorité des Marchés Financiers") - Merieux Equity Partners currently manages 5 main funds, representing more than €1 billion of Commitments, and has supported over 45 companies in Europe and North America since its creation - in Venture Capital and Growth/Buyout. Our passion is to work alongside entrepreneurs and companies with an ambitious growth plan, offering them privileged access to our sector-expertise and … Type: | 9 | 7 | 5 | 38 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 31 | 12 | 22 | 210 |
 | Supernova Invest European deeptech VC, focused on high-growing start-ups and cutting-edge technologies Supernova Invest is a European multi-stage VC firm with currently €800m AUM. Our team provides unparalleled expertise and smart capital in the fields of Healthcare, Energy & Environment, Industry 4.0, and Digital technologies to support high-growth, deeptech start-ups and scale them globally. We support disruptive tech companies such as Soitec, Ynsect, Alice & Bob, Gleamer, Aledia, Crowdsec, UnitySC and Robocath. The Supernova team exited +25 companies through top IPO and M&A deals. The team is composed of 25+ experienced investors with a unique ability to understand both the underlying technologies … Type: | 54 | 18 | 38 | 31 |
 | Kima Ventures We fund ambitious, cohesive teams with stellar learning and execution curves. Investing in 2 to 3 startups per week, all over the world. Type: | 43 | 33 | 1 | 19 |
 | Chausson Partners We match smart money with great companies Chausson Finance is a leading fundraising advisory firm, providing deal making and equity story advice, as well as devoted support to inspiring founders. We helped shape +250 deals, and raise $1Bn. Our community of clients include leadership teams funded by Accel, Balderton, Alven and other top venture investors. Fundraising, Corporate Finance, Venture Capital, investment banking, equity rounds, M&A, Series A, Series B, and Equity Financing Type: | 18 | 2 | 16 | 17 |
 | KREAXI Financing partner for innovative start-ups KREAXI is one of the top French leaders in seed and venture capital, with €150m under management, 550 companies invested since last 30 years (of which 27 went public), 60 active portfolio companies, with a team of 16 persons based in Lyon and Paris. Type: | 37 | 14 | 22 | 14 |
 | Cure51 From Cancer Survivors to new drugs The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer. Type: | 2 | 1 | 0 | 15 |
 | MaaT Pharma The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process … Type: | 25 | 8 | 21 | 77 |
 | Sensorion Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs … Type: | 12 | 6 | 6 | 69 |
 | Voisin Consulting Life Sciences (VCLS) Global reference partner to expedite access of HealthTech products to regulated markets. From discovery to product launch and lifecycle management At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 200 employees, VCLS serves a broad range of healthtech developers and their investors. Together, we accompany global stakeholders to expedite HealthTech … Type: | 6 | 1 | 4 | 234 |
 | Protera Smarter proteins for a sustainable future. By 2050, the world's population will surpass 10 billion people. To feed the current population and future generations we need to address global food challenges, today. How can we solve this problem without overwhelming the planet? And how can we deliver higher quality, more nutritious food for everyone? With Protera’s Natural IntelligenceTM technology, we believe the future is already here. Protera’s technology uses predictive algorithms that calculate millions of amino acid combinations and simulate protein patterns in a matter of seconds. Our technology is based in Deep Learning and allows us to shine a … Type: | 3 | 0 | 3 | 42 |
 | Italian Tech Alliance [Automatic translation follows] Formerly VC Hub Italia, it is the association of Venture Capital, investors in innovation, startups and innovative SMEs Italian Tech Alliance is the reference association for: - venture capital funds; - investors in innovation; - innovative startups and SMEs. The objective of the association is to promote the development of the technology and innovation ecosystem in Italy, working closely with institutions. The contents of the Italian Tech Alliance disseminate news, opportunities and interesting reports for private and public stakeholders who work for the economic and social growth of the country. The following currently sit on the Board … Type: | 7 | 3 | 3 | 15 |
 | HarperCollins Publishers Publishing great authors since 1817. HarperCollins Publishers is the second-largest consumer book publisher in the world. Headquartered in New York, HarperCollins has publishing operations in 17 countries. With two hundred years of history and more than 120 branded imprints around the world, HarperCollins publishes approximately 10,000 new books every year in 16 languages, and has a print and digital catalog of more than 200,000 titles. Writing across dozens of genres, HarperCollins authors include winners of the Nobel Prize, the Pulitzer Prize, the National Book Award, the Newbery and Caldecott Medals, and the Man Booker Prize. HarperCollins is a subsidiary of … Type: | 15 | 4 | 11 | 4,129 |
 | The Wall Street Journal Winner of 37 Pulitzer Prizes for outstanding journalism, The Wall Street Journal includes coverage of U.S. and world news, politics, arts, culture, lifestyle, sports, health and more. It's a critical resource of curated content in print, online and mobile apps, complete with breaking news streams, interactive features, video, online columns and blogs. Since 1889, readers have trusted the Journal for accurate, objective information to fuel their decisions as well as enlighten, educate and inspire them. On LinkedIn, we will share articles to help you navigate your career, including stories from our business, management, leisure and technology sections. Subscribe: http://on.wsj.com/1n1uvCH Job … Type: | 93 | 42 | 58 | 11,023 |
 | NatureWorks A naturally advanced biomaterials company using plants to turn greenhouse gases into IngeoTM️ PLA biopolymers. NatureWorks is an advanced materials company offering a broad portfolio of renewably-sourced polymers and chemicals to the packaging, polymers, fibers, and chemicals markets. With performance and economics that compete with oil-based plastics and fibers, naturally advanced IngeoTM polymers are valued for their unique functional properties and used in products from coffee capsules and electronics to diapers and wipes. Creating performance through chemistry, VercetTM lactide-based solutions help innovators realize significant, measurable performance and cost advantages in products such as C.A.S.E., toners, and surfactants. NatureWorks is jointly … Type: | 10 | 1 | 2 | 210 |
 | Cancer Campus [Automatic translation follows] Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne) Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne), around Gustave Roussy, the first cancer center in Europe. Its objective is to bring together all the talents (health professionals, researchers, students, businesses) and citizens concerned by the disease to become an international reference site in innovation in health and oncology. In this context, we are developing 3 programs dedicated to promoting entrepreneurship in oncology: - the Oncoentrepreneur program: tailor-made training and support set up for start-up projects in biotech, medtech and e-health. … Type: | 5 | 1 | 3 | 3 |
 | Marks & Clerk Leading global network of intellectual property specialists We’re true specialists – focusing on IP and IP alone. With patent attorneys, trade mark attorneys, commercial lawyers and IP litigators, we can provide every type of intellectual property service you need. Our expertise is globally acknowledged - in our top tier status, the awards we’ve won and in the cutting-edge work we do, which helps shape future law. Intellectual property, Litigation, Prosecution, Patents, Trade Marks, and Law | 3 | 1 | 1 | 587 |
 | GENFIT Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC). Today, … Type: | 7 | 3 | 5 | 172 |
 | Varenne Capital Partners Varenne Capital Partners is a Paris-based, process-driven, global investment manager whose purpose is to deliver superior long-term returns with the minimum necessary risk-taking. We strive to achieve this goal by employing proprietary research and combining complementary investment frameworks in a single strategy: Long Equity, Short Equity, Merger Arbitrage and Tail Risk Hedging. Our ‘brokers are not welcome’ policy means that we rely exclusively on our own internal research and base our analysis on facts and figures. All of our investment frameworks stem from years of research and development and as a result comprise original methodologies, formalized processes, dedicated teams of … Type: | 5 | 2 | 1 | 38 |
 | GFBiochemicals GFBiochemicals is on a mission to create a more sustainable future and transform the chemicals industry GFBiochemicals is a biochemical company that specializes in the research, development, production and business development of bio-based and renewable chemicals. We provide high-quality, bio-based chemicals to businesses across the world. Our focus is green chemistry – a sustainable alternative to traditional oil-based chemistry. Our technology is proprietary and has been developed in-house over many years. GFBiochemicals is headquartered in Paris, France and has subsidiaries in Geleen, the Netherlands and Minneapolis, USA. GFBiochemicals acquired Segetis, in 2016, as part of our growth strategy to integrate … Type: | 5 | 2 | 3 | 33 |
 | Quest for health [Automatic translation follows] Healthcare accelerator in the heart of Europe. For biotech, medtech and digital health startups. Quest for health is the Grand Est incubator dedicated to health start-ups at European level. Born from the initiative of the Quest for change network of incubators (based in Reims, Strasbourg, Metz, Charleville-Mézières, Epinal and Mulhouse), the incubator supports more than sixty biotech, medtech and e-health start-ups. Quest for health is positioned as the leading player at the national level in this field. Among the start-ups supported, 21 are winners of the national i-Lab competition (including four grand prizes), five of the i-Nov … Type: | 40 | 11 | 38 | 6 |
 | Groupe Stratos Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Our community is composed of entrepreneurs with expertise on a specific topic and each single member is/was an entrepreneur. Groupe STRATOS was founded in 2020 with the merger of 2 other companies created 10 & 20 years ago. About our advisory activiy : - Fund raisings through our network of +1 000 investors (France & International) - Mergers & Acquisitions - Financial audits (M&A, valuation of companies, due diligence...) - Financial analysis - Strategy & business development - … Type: | 54 | 2 | 54 | 8 |
 | France Deeptech [Automatic translation follows] When science undertakes The community that brings together deeptech players for an entrepreneurial, collective and scientific response to our contemporary challenges Type: | 42 | 9 | 39 | 6 |
 | IMS (Institut du Médicament de Strasbourg) [Automatic translation follows] Interdisciplinary Thematic Institute of the University of Strasbourg The Strasbourg Medicine Institute responds to the challenges of the medicines sector: producing cutting-edge research up to the pre-clinical stage, promoting technological innovation through the creation of start-ups and training the new generation of researchers in management of drug innovation. Type: | 13 | 2 | 7 | 6 |
 | HealthTech For Care An endowment fund to support and promote access to care for all patients as well as new medical and drug technologies. The HealthTech For Care endowment fund has three essential missions: - fostering the growth and development of the entire health ecosystem, - advocating for the advancement of innovative therapies and treatments to benefit patients, - promoting enhanced access to care for patients within the European healthcare ecosystem. The HealthTech For Care endowment fund has been founded by France Biotech. Health Type: | 22 | 5 | 20 | 8 |
 | Private Equity Magazine [Automatic translation follows] The monthly magazine for private equity professionals Find the latest news from investment capital professionals on our site and our magazine. Deals, surveys and analyses, with a cumulative audience of more than 30,000 readers, Private Equity Magazine has become for 10 years the reference publication for French and European private equity players. Type: | 75 | 12 | 72 | 8 |
 | Biotalys Reinventing food protection We are a rapidly growing and transformative food and crop protection company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of effective and safe products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are … Type: | 6 | 3 | 5 | 69 |
 | RefleXion Medical SCINTIX biology-guided radiotherapy is now FDA cleared. SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease. cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering Type: | 2 | 2 | 1 | 240 |
 | Inspirna, Inc. Converting cancer to a manageable, chronic condition Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE … Type: | 2 | 2 | 0 | 33 |
 | Artios Taking control of the DNA Damage Response (DDR) Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. … Type: | 7 | 3 | 0 | 113 |
 | ProQR Therapeutics Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing Type: | 3 | 3 | 1 | 163 |
 | May Health We are bringing a modern approach to the treatment of PCOS with our investigational Ovarian Rebalancing Treatment. May Health, formerly AblaCare, is developing a modern approach to PCOS. Type: | 1 | 1 | 1 | 16 |
 | Bioptimus We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models Type: | 4 | 2 | 3 | 13 |
 | CONCILIO Your key to better care. Concilio gives you access to the best in health care. In a world where doctors are becoming super-specialized, it’s not always easy to obtain reliable information and to know exactly who to turn to for your specific medical issue. As the first digital medical concierge service, Concilio aims to democratize access to the best in health care. Wherever you are in the world, our dedicated medical team is there to help you every day with more than 5 000 pathologies. E-santé, Téléconsultation, Recherche de Médecins, Bilan Santé, téléconseil médical, télémédecine, Médecins généralistes, Médecins Spécialistes, Conciergerie … Type: | 16 | 5 | 9 | 41 |
 | IXO PRIVATE EQUITY [Automatic translation follows] iXO Private Equity. Invest, Invest, Succeed, Together iXO Private Equity is a management company which mainly carries out LBO and development capital transactions. Its team is made up of 19 people, including 14 professional investors with complementary experience. iXO Private Equity is one of the largest independent French players in the small and mid-cap sector. The management company, based in Toulouse, now manages more than €610 million in assets and invests between €2 and €15 million in equity per project, primarily in companies in the greater South of France and Rhône-Alpes. Type: | 35 | 11 | 28 | 32 |
 | Meridiam For people and the planet - delivering transformational infrastructure, for the long term. Meridiam was founded in 2005 by Thierry Déau, with the belief that the alignment of interests between the public and private sector can provide critical solutions to the collective needs of communities. Meridiam is an independent investment Benefit Corporation and an asset manager. The firm specializes in the development, financing, and long-term management of sustainable public infrastructure in three core sectors: sustainable mobility, critical public services and innovative low carbon solutions. With offices in Addis Ababa, Amman, Dakar, Istanbul, Luxembourg, Paris, Vienna, Libreville, Johannesburg and Washington, Meridiam … Type: | 66 | 20 | 42 | 355 |
 | Andera Partners The Power of And Created over 20 years ago, Andera Partners is a major player in private company investments in France and internationally. Its teams manage over €3.6 billion in investments in life sciences (Andera Life Sciences), growth and buyout capital (Andera MidCap, Andera Expansion, Andera Croissance, Andera Co-Invest), sponsorless transactions (Andera Acto) and ecological transition (Andera Infra). Andera Partners’ mission is to work alongside companies and their managers to support them in achieving strong and sustainable growth. The quality of performance offered to our investors relies on a strong partnership between the entrepreneurs in our portfolio companies and our … Type: | 31 | 17 | 18 | 130 |
 | Les Echos [Automatic translation follows] Find on LesEchos.fr all the economic and financial news in France and around the world, discover exclusive analyses, special reports, decryptions, chronicles and large formats. http://www.lesechos.fr/ Type: | 376 | 242 | 148 | 700 |
 | Palais de Tokyo [Automatic translation follows] Contemporary art center, Paris 📍 🔛 Mohamed Bourouissa, Dislocations, Touch the insane, Past disquiet With its 22,000 m2, the Palais de Tokyo stands out through its energy as one of the largest contemporary art centers in Europe. It encourages contemporary creation with an eclectic and inventive program around emerging and established artists from all backgrounds. contemporary art, exhibitions, performances, and concerts Type: | 13 | 7 | 7 | 163 |
 | Rothschild & Co We offer a distinct perspective that makes a meaningful difference to our clients' business and wealth. Rothschild & Co is one of the world's largest independent financial advisory groups. We offer a distinct perspective that makes a meaningful difference to our clients’ business and wealth. With a team of 4,200 talented financial services specialists on the ground in more than 40 countries across the world, we provide independent advice on M&A, strategy and financing, as well as investment and wealth management solutions to large institutions, families, individuals and governments. As a family-controlled business that has been at the centre of … Type: | 26 | 19 | 7 | 5,455 |
 | BIOWEG Revolutionizing the Future of Bio-ingredients BIOWEG, founded in 2019 in Germany, is a purpose-driven organization powered by conscious ChemDesign. We match Bio-innovation to business problems. We explore and combine biotechnology, material science, and molecular simulation learning to create advanced sustainable bio-based high-performance ingredients. Our ingredients are 100% animal free, globally scalable, and sustainably produced without harsh chemicals. We work with results-oriented, forward-thinking companies, and consumer brands with global scale in the cosmetics, personal care, nutraceuticals, agricultural coatings, and food/beverage sectors who desire highly differentiated and sustainable science-based ingredient technologies. Material Science, Fermentation , Green Chemistry, Alternative Ingredients, Biobased Materials, Biodegradabe, … Type: | 22 | 3 | 2 | 20 |
 | ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: | 8 | 3 | 5 | 31 |
 | RebrAIn ReBrain standardizes targeting for DBS and brain lesion surgeries in Parkinson and essential tremor diseases RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated. Type: | 10 | 6 | 6 | 12 |
 |  Catsalyze We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze. Type: | 22 | 2 | 21 | 2 |
 | Talas Partners [Automatic translation follows] The right financing at the right time! Talas Partners is your partner of excellence to propel your company's innovation towards new horizons. Who are we ? Much more than a simple innovation financing consultancy firm, we become your partner to achieve your entrepreneurial objectives and lead you towards success. Our passion is to transform each innovative project into a successful entrepreneurial success. Our mission We have a clear mission: to help Startups and SMEs develop their businesses by mobilizing public or private financing. Our Support Present in the innovation ecosystem for a very long time, we guide … Type: | 4 | 1 | 3 | 3 |
 | GAE Conseil [Automatic translation follows] Expert in the prevention of addictive practices in professional environments: advice, awareness, training, etc. G.A.E Conseil, the leading player in the prevention of addictive practices at work. Founded in 2014, GAE Conseil is an independent consulting firm specializing in the prevention of addictive practices in professional environments (psychoactive products and behavioral addictions). Around the partners of the firm and the heads of the different centers of expertise (Audit and Consulting Center, Training Center, Assistance Center for employees in difficulty), the GAE Conseil teams support private and public companies of all sizes and of all types. sectors of … Type: | 44 | 0 | 43 | 36 |
 | M&M Conseil [Automatic translation follows] Public affairs - Institutional relations M&M Conseil has specialized in the organization of institutional events and public affairs consulting for more than 25 years. Close to French and European institutions, we organize key meetings between public, private and institutional stakeholders. Public Affairs Consulting, Institutional Communication, Events, and Public Relations Type: | 86 | 6 | 83 | 8 |
 | GOURMEY 🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. [join.gourmey.com] GOURMEY is France's pioneering cultivated meat company. 🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. > Join.gourmey.com Type: | 33 | 9 | 27 | 95 |
 | datacraft [Automatic translation follows] The data scientists club datacraft allows an exchange of best practices between data experts. It is a unique Club model, inspired by companionship, and designed to allow data scientists/data engineers to train among peers and enable companies to accelerate their AI/data projects. Access to the Club is through an annual membership. Type: | 47 | 8 | 34 | 16 |
 | Gradient Denervation Technologies Transforming the treatment of pulmonary hypertension A solution for patients suffering from heart failure with pulmonary hypertension. Type: | 1 | 1 | 0 | 13 |
 | Moon Surgical Empowering the Surgeon Moon Surgical aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics. medical device, minimally invasive surgery, digital surgery, comanipulation, AI, Machine Learning, Surgery, Laparoscopy, and Surgical Robotics Tags: FrenchTech2030 Type: | 12 | 7 | 6 | 55 |
 | Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences Type: | 4 | 1 | 3 | 18 |
 | TAC ECONOMICS An independent European research group providing advisory services on international economic and financial issues TAC ECONOMICS is a French independent leading provider of economic and financial consulting services with a strong expertise on country risk based on AI and data-driven solutions. Our team of experienced economists and data scientists specializes in providing cutting-edge data, models, and analysis to help our clients detect major risks and evaluate investment opportunities. Our commitment to AI and data-driven solutions is rooted in our pioneering work in the early 1990s, where we developed artificial intelligence tools to predict financial crises in emerging economies and prevent … | 6 | 1 | 3 | 12 |
Media